GeneHub is a clinical trials accelerator that connects patients with drug developers to enhance access to relevant medications. The platform streamlines patient recruitment and data collection, addressing the inefficiencies in clinical trial processes that delay drug availability.
Funding
$140K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Clinical trials often face challenges in patient recruitment and data collection, leading to delays in drug development and accessibility. Inefficient processes and difficulties in connecting patients with relevant trials contribute to these bottlenecks.
Solution
GeneHub is a platform designed to accelerate clinical trials by directly connecting patients with drug developers. The platform streamlines the processes of patient recruitment and data collection, addressing key inefficiencies that traditionally slow down the availability of new medications. By facilitating a more direct and efficient interaction between patients and researchers, GeneHub aims to expedite the clinical trial process, ultimately bringing new treatments to market faster.
Target Audience
GeneHub primarily targets pharmaceutical companies, biotechnology firms, and clinical research organizations seeking to improve the efficiency of their clinical trials, as well as patients looking for access to cutting-edge treatments through participation in research studies.
Features
- Patient matching algorithms to connect individuals with relevant clinical trials based on their medical profiles.
- Secure data collection and management tools to streamline the gathering of patient data during trials.
- Communication platform to facilitate direct interaction between patients and drug developers.
- Real-time tracking and reporting features to monitor trial progress and identify potential issues.